ESOPJul 10, 2026, 04:03 PM
BridgeBio Grants 83,283 RSUs to 37 New Employees
AI Summary
BridgeBio Pharma, Inc. announced that its compensation committee approved equity grants to 37 new employees on July 7, 2026. These grants consist of restricted stock units (RSUs) for an aggregate of 83,283 shares of the company's common stock. The awards were granted as an inducement for employees to join the company, with a vesting schedule beginning in August 2027.
Key Highlights
- Equity grants approved for 37 new employees.
- Aggregate of 83,283 shares of common stock granted as restricted stock units (RSUs).
- One-fourth of shares vest on August 16, 2027.
- Remaining shares vest quarterly thereafter.
- Grants are subject to continued employment.
- Awards granted as inducement in accordance with Nasdaq Listing Rule 5635(c)(4).
- Grants made under a plan adopted in November 2019 and amended in February and December 2023.
Price Impact
More from BBIO